Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Chi, CC; Kirtschig, G; Aberer, W; Gabbud, JP; Lipozenčić, J; Kárpáti, S; Haustein, UF; Wojnarowska, F; Zuberbier, T.
Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.
J Eur Acad Dermatol Venereol. 2017; 31(5):761-773 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Aberer Werner
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Topical corticosteroids may be needed for treating skin conditions in pregnancy. Nevertheless, only limited data on the fetal effects of topical corticosteroids are available. To update an evidence-based guideline on the safe use of topical corticosteroids in pregnancy. A guideline subcommittee of the European Dermatology Forum updated the guideline by adding and appraising new evidence. The current best evidence from 14 observational studies with 1 601 515 study subjects found no significant associations between maternal use of topical corticosteroids of any potency and some adverse pregnancy outcomes including mode of delivery, birth defect, preterm delivery and fetal death. However, maternal use of potent/very potent topical corticosteroids, especially in large amounts, is associated with an increase in the risk of low birthweight. Mild/moderate topical corticosteroids should be preferred to potent/very potent ones in pregnancy. The well-known topical side-effects of corticosteroids on the mother's side need to be considered as well. © 2017 European Academy of Dermatology and Venereology.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Topical -
Adrenal Cortex Hormones - administration & dosage
Adrenal Cortex Hormones - adverse effects
Animals -
Europe -
Evidence-Based Medicine -
Female -
Humans -
Practice Guidelines as Topic -
Pregnancy -

© Meduni Graz Impressum